Literature DB >> 12021145

Immunomodulatory effect of tungstate on streptozotocin-induced experimental diabetes in rats.

R Palanivel1, D Sakthisekaran.   

Abstract

Immune dysfunction has been found to be associated with diabetes mellitus. Tungstate treatment restored the number and function of immune cells as well as the immunoglobulin level in STZ diabetic rats. This indicated the immunomodulatory effect of tungstate in diabetics and would be effective in inhibiting diabetic-induced alterations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12021145     DOI: 10.1111/j.1749-6632.2002.tb03008.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  2 in total

1.  In vivo sodium tungstate treatment prevents E-cadherin loss induced by diabetic serum in HK-2 cell line.

Authors:  Romina Bertinat; Pamela Silva; Elizabeth Mann; Xuhang Li; Francisco Nualart; Alejandro J Yáñez
Journal:  J Cell Physiol       Date:  2015-10       Impact factor: 6.384

2.  Preclinical and Clinical Studies for Sodium Tungstate: Application in Humans.

Authors:  Romina Bertinat; Francisco Nualart; Xuhang Li; Alejandro J Yáñez; Ramón Gomis
Journal:  J Clin Cell Immunol       Date:  2015-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.